Skip to main content
Equibles

Clark Capital Management Group, Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1352187 PHILADELPHIA, PA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$18,155,196
+$4,317,784 QoQ
Shares Held
231,956
+8.3% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#88
of 667 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Clark Capital Management Group, Inc. holds $136,817,304 across 5 Biotechnology names. HALO ranks #2 (13.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 1,663,003 $93,244,578
2 HALO
Halozyme Therapeutics, Inc.
This page 		231,956 $18,155,196
3 EXEL
Exelixis, Inc.
 271,878 $14,792,881
4 LGND
Ligand Pharmaceuticals Inc
 32,948 $10,414,533
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 423 $210,116

All Filings in HALO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,155,196 231,956
2026-03-31 $13,837,412 214,102
2025-12-31 $9,683,527 143,886
2025-09-30 $14,885,453 202,965
2025-06-30 $9,227,463 177,383
2025-03-31 $13,129,673 205,762
2024-12-31 $8,549,718 178,827
2024-09-30 $7,851,725 137,172
2024-06-30 $5,389,153 102,925
2023-03-31 $1,131,798 29,636
2022-12-31 $1,970,048 34,623
2022-09-30 $1,328,702 33,604
2022-06-30 $1,485,704 33,766
2021-12-31 $2,220,476 55,222
2021-09-30 $2,354,273 57,873